Millendo Therapeutics, Inc.
MLND · NASDAQ
12/31/2024 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$41,843 | -$36,406 | -$44,568 | -$27,192 |
| Dep. & Amort. | $389 | $1,104 | $1,052 | $32 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $5,303 | $4,244 | $4,317 | $1,427 |
| Change in WC | $0 | $296 | -$2,053 | $1,036 |
| Other Non-Cash | $36,151 | $327 | $30 | $1,050 |
| Operating Cash Flow | $0 | -$30,435 | -$41,222 | -$23,647 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$435 | -$26 | -$397 | -$36 |
| Net Acquisitions | $0 | $0 | $0 | -$524 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $4,385 | $2,492 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$435 | -$26 | $3,988 | $1,932 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $28,591 | $5,453 | $26,673 | $38,756 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $24,500 | $5,386 | $26,943 | $77,744 |
| Financing Cash Flow | $24,500 | $5,386 | $26,943 | $77,744 |
| Forex Effect | $0 | $221 | $33 | $118 |
| Net Chg. in Cash | -$8,962 | -$24,854 | -$10,258 | $56,147 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $39,673 | $63,512 | $73,770 | $17,623 |
| End Cash | $30,711 | $38,658 | $63,512 | $73,770 |
| Free Cash Flow | -$435 | -$30,461 | -$41,619 | -$23,683 |